Protein therapeutics have changed the face of modern medicine in the past decade as they provide innovative and effective therapies for numerous previously refractory illnesses. Besides, the fast developments in protein therapeutics have had a positive impact on the pharmaceutical and biotech industries. The number of protein based pharmaceuticals reaching the marketplace has exponentially increased over the past few years. With increasing demand for innovative protein therapeutics each year, existing as well as new players are making huge investment into this market. Moreover, new developments in manufacturing & production technology have led to significant advancements in protein manufacturing and production.
According to our new research report “Global Protein Therapeutics Market Analysis”, the global protein therapeutics market is expected to grow at a CAGR of around 12% during 2010-2013. At present, the market is characterized by high cost treatments therapy and healthcare insurance which in turn helping the companies to generate more revenue. With the advent of new technologies and genetic and chemical techniques, the protein therapeutics industry has ensured a competitive edge in developing improved protein and peptide based therapeutics.
Our report has found that the market is presently dominated by Monoclonal Antibodies. With double-digit growth projected for future, this segment is expected to bolster its dominant position. Smaller companies are likely to become more visible as their products move closer to regulatory approval.
Further, Insulin, Interferon Beta, G-CSF and coagulation factors are also exhibiting healthy growth rates. One of the biggest opportunity areas in the protein therapeutics market is bio-generics which are expected to create a multi-billion dollar market in future. The pharmaceutical contract research and manufacturing market is expected to grow at an unmatched rate on account of high cost factor.
The report provides extensive information and rational analysis of the global protein therapeutics market. It has thoroughly examined current market trends, industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years. The report also gives an insight into the segment-wise market trends prevailing at the regional level to provide an overview of developments taking place in these segments across the world.
The report also facilitates in comprehending the market inhibitors that need collective and strategic evaluation to foster growth in the protein therapeutics market. The key player section includes information about the business operation and SWOT analysis of leading firms. The forecast given in the report is based on correlation between the market trends and drivers.
